NCT05131087View on ClinicalTrials.gov

A First-In-Human Clinical Trial to Evaluate the Safety, Effectiveness and Surgical Characteristics of CADENCE in Patients With Refractory Glaucoma

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

July 5, 2023

Study Completion Date

July 5, 2023

Conditions
Glaucoma
Interventions
DEVICE

Cadence implant

CADENCE Glaucoma Drainage Device System is a single use implantable glaucoma drainage device used for the surgical treatment of refractory glaucoma. The device is implanted in the eye using an ab-externo approach

Trial Locations (1)

72530

Clinica Laser y Ultrasonido Ocular de Puebla, Puebla City

All Listed Sponsors
lead

New World Medical, Inc.

INDUSTRY

NCT05131087 - A First-In-Human Clinical Trial to Evaluate the Safety, Effectiveness and Surgical Characteristics of CADENCE in Patients With Refractory Glaucoma | Biotech Hunter | Biotech Hunter